Clinical trial
Desmopressin as a Therapy for Nocturnal Enuresis in Patients With Sickle Cell Disease
NCT02636387 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Desmopressin as a Therapy for Nocturnal Enuresis in Patients With Sickle Cell Disease
- Lead sponsor
- Montefiore Medical Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 26, 2015
- Completion date
- October 27, 2018
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.